Archive

We need a new blueprint for stability.

New book reveals how and why hedge-fund activists have been able to suck the life from big-name companies like J.C. Penney and Samsung with their short-sighted profit-grabs. Can their harmful activities be stopped?

Automatic enrollment in retirement plans is a game-changer, but it also brings unexpected consequences.

If there is no universally accepted outside authority to tell us how to judge theories then knowledge is only going to progress by means of debate

The Economics Group at Azim Premji University, Bhopal, India, in collaboration with the Institute for New Economic Thinking and its Young Scholars Initiative (INET-YSI), is pleased to announce an international conference aimed at exploring the intricate relationships between social identities, institutions, and economic development in South Asia.

The power of mutual funds to influence economic and social choices through their voting behavior points to deeper ideologies driving institutional investors.

Fifty years ago the actions of the Federal Reserve mattered. Today, so far as the aggregate measures of the American domestic economy go, they do not.

Sociologist Michael A. McCarthy’s latest book shows how ordinary people can take back control of financial capitalism and make it work for them.

The country’s flawed insurance model, driven by greed, leads to inefficiency, inequality, and denied care - a colossal scam that has sparked fury across the nation.

An interview with Thomas Ferguson on the 2024 US election conducted by Andrew Yamakawa Elrod and Tim Barker for Phenomenal World

Industrial organization economists have caused antitrust to cling to an antiquated and disproven economic theory.

Welfare economists and moral philosophers have shown that the Consumer Welfare Standard is biased in favor of wealthy individuals and corporations—the very powers the antitrust law is supposed to regulate.

Phenomenal World

Dr. Victor Gurewich, a researcher and Harvard Medical School faculty member since 1965, discovered a breakthrough drug treatment for heart attacks and strokes with the potential to save millions, but institutional resistance and a U.S. healthcare system that puts profits over patients are keeping it out of reach.

EMC brings together the thinkers and doers, with insights and inter-disciplinary perspectives on emerging markets. It is about cutting edge ideas, the discussion at the frontiers, and achieving a strategic sense.